Extracellular vesicle therapy for retinal diseases

B Mead, S Tomarev - Progress in retinal and eye research, 2020 - Elsevier
Extracellular vesicles (EV), which include exosomes and microvesicles, are secreted from
virtually every cell. EV contain mRNA, miRNA, lipids and proteins and can deliver this …

Advances in bone marrow stem cell therapy for retinal dysfunction

SS Park, E Moisseiev, G Bauer, JD Anderson… - Progress in retinal and …, 2017 - Elsevier
The most common cause of untreatable vision loss is dysfunction of the retina. Conditions,
such as age-related macular degeneration, diabetic retinopathy and glaucoma remain …

Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion

B Mathew, S Ravindran, X Liu, L Torres… - Biomaterials, 2019 - Elsevier
Retinal ischemia is a major cause of vision loss and impairment and a common underlying
mechanism associated with diseases such as glaucoma, diabetic retinopathy, and central …

Human mesenchymal stem cell secretome driven T cell immunomodulation is IL-10 dependent

MT Shephard, MM Merkhan, NR Forsyth - International Journal of …, 2022 - mdpi.com
The Human Mesenchymal Stem Cell (hMSC) secretome has pleiotropic effects
underpinning its therapeutic potential. hMSC serum-free conditioned media (SFCM) …

Reactive oxygen species‐responsive mitochondria‐targeted liposomal quercetin attenuates retinal ischemia–reperfusion injury via regulating SIRT1/FOXO3A and …

L Zhao, L Ling, J Lu, F Jiang, J Sun… - Bioengineering & …, 2023 - Wiley Online Library
Retinal ischemia–reperfusion (RIR) injury is involved in the pathogenesis of various vision‐
threatening diseases. The overproduction of reactive oxygen species (ROS) is thought to be …

MicroRNA-based engineering of mesenchymal stem cell extracellular vesicles for treatment of retinal ischemic disorders: Engineered extracellular vesiclesand retinal …

B Mathew, LG Acha, LA Torres, CC Huang, A Liu… - Acta biomaterialia, 2023 - Elsevier
Mesenchymal stem cell (MSCs)-derived extracellular vesicles (EVs) are emerging
therapeutic tools. Hypoxic pre-conditioning (HPC) of MSCs altered the production of …

Physoxia alters human mesenchymal stem cell secretome

MM Merkhan, MT Shephard… - Journal of Tissue …, 2021 - journals.sagepub.com
The human mesenchymal stem cell (hMSC) secretome has pleiotropic effects which
underpin their therapeutic potential. hMSC serum-free conditioned media (SFCM) has been …

Protective effect of intravitreal administration of exosomes derived from mesenchymal stem cells on retinal ischemia

E Moisseiev, JD Anderson, S Oltjen… - Current eye …, 2017 - Taylor & Francis
Purpose: Exosomes derived from human mesenchymal stem cells (hMSCs) cultured under
hypoxic conditions contain proteins and growth factors that promote angiogenesis. This …

TNFα-mediated priming of mesenchymal stem cells enhances their neuroprotective effect on retinal ganglion cells

B Mead, X Chamling, DJ Zack… - … & visual science, 2020 - iovs.arvojournals.org
Purpose: To determine whether priming of bone marrow mesenchymal stem cells (MSCs) by
signals from injured retina, particularly tumor necrosis factor α (TNFα), increase their …

Potent paracrine effects of human induced pluripotent stem cell-derived mesenchymal stem cells attenuate doxorubicin-induced cardiomyopathy

Y Zhang, X Liang, S Liao, W Wang, J Wang, X Li… - Scientific reports, 2015 - nature.com
Transplantation of bone marrow mesenchymal stem cells (BM-MSCs) can protect
cardiomyocytes against anthracycline-induced cardiomyopathy (AIC) through paracrine …